We are live on ! Find out more
LLY icon

Eli Lilly

1,005 hedge funds and large institutions have $42.1B invested in Eli Lilly in 2013 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 341 increasing their positions, 406 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 69

11% more call options, than puts

Call options by funds: $460M | Put options by funds: $416M

3% more funds holding

Funds holding: 9741,005 (+31)

2% more capital invested

Capital invested by funds: $41.1B → $42.1B (+$950M)

0.62% more ownership

Funds ownership: 72.69%73.31% (+0.62%)

16% less repeat investments, than reductions

Existing positions increased: 341 | Existing positions reduced: 406

17% less funds holding in top 10

Funds holding in top 10: 2319 (-4)

Holders
1,005
Holders Change
+31
Holders Change %
+3.18%
% of All Funds
29.16%
Holding in Top 10
19
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-17.39%
% of All Funds
0.55%
New
112
Increased
341
Reduced
406
Closed
69
Calls
$460M
Puts
$416M
Net Calls
+$44.3M
Net Calls Change
-$109M
Name Holding Trade Value Shares
Change
Change in
Stake
Caisse de Depot et Placement du Quebec (CDPQ)
151
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$28.5M +$1.93M +38,600 +7%
ASRS
152
Arizona State Retirement System
Arizona
$28.4M -$1.41M -28,100 -5%
Korea Investment Corp
153
Korea Investment Corp
South Korea
$27.9M -$3.49M -69,700 -11%
CA
154
Commerzbank Aktiengesellschaft
Germany
$27.9M -$9.32M -186,097 -26%
SAM
155
Sentinel Asset Management
Vermont
$27.2M +$1.35M +26,870 +5%
Comerica Bank
156
Comerica Bank
Texas
$27M -$4.44M -88,644 -14%
BNP Paribas Financial Markets
157
BNP Paribas Financial Markets
France
$27M -$4.4M -87,824 -14%
BKBG
158
BHF Kleinwort Benson Group
Belgium
$26.9M +$7.03M +140,342 +36%
AC
159
Ascend Capital
California
$26.5M +$22M +439,114 +549%
Millennium Management
160
Millennium Management
New York
$26.2M -$3.98M -79,514 -13%
SOMRS
161
State of Michigan Retirement System
Michigan
$25.4M -$10K -200 -0%
Credit Agricole
162
Credit Agricole
France
$25.1M -$1.98M -39,467 -7%
TG
163
TCW Group
California
$25M +$30K +600 +0.1%
ERSOT
164
Employees Retirement System of Texas
Texas
$24.9M +$3.99M +79,600 +20%
VOYA Investment Management
165
VOYA Investment Management
Georgia
$24.5M +$497K +9,916 +2%
GT
166
Glenmede Trust
Pennsylvania
$24.1M -$49.6K -991 -0.2%
MWNA
167
Marshall Wace North America
New York
$23.4M +$16.5M +330,471 +256%
Macquarie Group
168
Macquarie Group
Australia
$23.4M +$458K +9,150 +2%
TPSF
169
Texas Permanent School Fund
Texas
$23.4M -$1.71M -34,199 -7%
DekaBank Deutsche Girozentrale
170
DekaBank Deutsche Girozentrale
Germany
$22.2M -$818K -16,338 -4%
Pzena Investment Management
171
Pzena Investment Management
New York
$22M -$55.1K -1,100 -0.3%
SCM
172
Stevens Capital Management
Pennsylvania
$21.9M -$12.5M -248,749 -37%
Calamos Advisors
173
Calamos Advisors
Illinois
$21.6M
PI
174
PineBridge Investments
New York
$21.5M -$840K -16,783 -4%
KCM
175
Kornitzer Capital Management
Kansas
$21.2M -$3.1M -61,905 -13%

LLY Hedge Fund Activity: Q4 2013 in Review

1,005 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q4 2013, worth a combined $42.1B — up 2.3% from $41.1B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new LLY positions and 69 closed out — a net gain of 43 holders — while 341 added to existing stakes and 406 trimmed.

The largest buyer was Franklin Resources, adding an estimated $711M. The largest seller was Fidelity Investments, cutting an estimated $141M.

  • 1,005 institutional investors held Eli Lilly (LLY) as of Q4 2013, up from 974 in Q3 2013.
  • Funds reported $42.1B of Eli Lilly stock for Q4 2013, up 2.3% quarter-over-quarter.
  • 112 funds opened new Eli Lilly positions in Q4 2013 and 69 closed out, a net change of +43 holders.
  • The largest Eli Lilly buyer in Q4 2013 was Franklin Resources, an estimated $711M added.
  • The largest Eli Lilly seller in Q4 2013 was Fidelity Investments, an estimated $141M sold.

Based on aggregated 13F filings for Q4 2013.